These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21183371)

  • 1. Autism associated with low 5-hydroxyindolacetic acid in CSF and the heterozygous SLC6A4 gene Gly56Ala plus 5-HTTLPR L/L promoter variants.
    Adamsen D; Meili D; Blau N; Thöny B; Ramaekers V
    Mol Genet Metab; 2011 Mar; 102(3):368-73. PubMed ID: 21183371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced activity of human serotonin transporter variants associated with autism.
    Prasad HC; Steiner JA; Sutcliffe JS; Blakely RD
    Philos Trans R Soc Lond B Biol Sci; 2009 Jan; 364(1514):163-73. PubMed ID: 18957375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin transporter promoter variants: Analysis in Indian autistic and control population.
    Guhathakurta S; Ghosh S; Sinha S; Chatterjee A; Ahmed S; Chowdhury SR; Gangopadhyay PK; Ghosh S; Singh M; Usha R
    Brain Res; 2006 May; 1092(1):28-35. PubMed ID: 16674932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of evidence for association of the serotonin transporter gene SLC6A4 with autism.
    Ramoz N; Reichert JG; Corwin TE; Smith CJ; Silverman JM; Hollander E; Buxbaum JD
    Biol Psychiatry; 2006 Jul; 60(2):186-91. PubMed ID: 16616719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-HTTLPR Genotype-Specific Phenotype in Children and Adolescents With Autism.
    Brune CW; Kim SJ; Salt J; Leventhal BL; Lord C; Cook EH
    Am J Psychiatry; 2006 Dec; 163(12):2148-56. PubMed ID: 17151167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin transporter gene promoter polymorphism and autism: a family-based genetic association study in Japanese population.
    Koishi S; Yamamoto K; Matsumoto H; Koishi S; Enseki Y; Oya A; Asakura A; Aoki Y; Atsumi M; Iga T; Inomata J; Inoko H; Sasaki T; Nanba E; Kato N; Ishii T; Yamazaki K
    Brain Dev; 2006 May; 28(4):257-60. PubMed ID: 16481140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autism spectrum disorder associated with low serotonin in CSF and mutations in the SLC29A4 plasma membrane monoamine transporter (PMAT) gene.
    Adamsen D; Ramaekers V; Ho HT; Britschgi C; Rüfenacht V; Meili D; Bobrowski E; Philippe P; Nava C; Van Maldergem L; Bruggmann R; Walitza S; Wang J; Grünblatt E; Thöny B
    Mol Autism; 2014; 5():43. PubMed ID: 25802735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SLC6A4 markers modulate platelet 5-HT level and specific behaviors of autism: a study from an Indian population.
    Jaiswal P; Guhathakurta S; Singh AS; Verma D; Pandey M; Varghese M; Sinha S; Ghosh S; Mohanakumar KP; Rajamma U
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jan; 56():196-206. PubMed ID: 25261775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin transporter gene promoter region polymorphisms and serotonin transporter expression in the colonic mucosa of irritable bowel syndrome patients.
    Wang YM; Chang Y; Chang YY; Cheng J; Li J; Wang T; Zhang QY; Liang DC; Sun B; Wang BM
    Neurogastroenterol Motil; 2012 Jun; 24(6):560-5, e254-5. PubMed ID: 22435794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral cortical gray matter overgrowth and functional variation of the serotonin transporter gene in autism.
    Wassink TH; Hazlett HC; Epping EA; Arndt S; Dager SR; Schellenberg GD; Dawson G; Piven J
    Arch Gen Psychiatry; 2007 Jun; 64(6):709-17. PubMed ID: 17548752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel neurodevelopmental syndrome responsive to 5-hydroxytryptophan and carbidopa.
    Ramaekers VT; Senderek J; Häusler M; Häring M; Abeling N; Zerres K; Bergmann C; Heimann G; Blau N
    Mol Genet Metab; 2001 Jun; 73(2):179-87. PubMed ID: 11386854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variants of the serotonin transporter gene (SLC6A4) significantly contribute to hyperserotonemia in autism.
    Coutinho AM; Oliveira G; Morgadinho T; Fesel C; Macedo TR; Bento C; Marques C; Ataíde A; Miguel T; Borges L; Vicente AM
    Mol Psychiatry; 2004 Mar; 9(3):264-71. PubMed ID: 15094787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin and serotonin transporter gene variant in rotating shift workers.
    Sookoian S; Gemma C; Gianotti TF; Burgueño A; Alvarez A; González CD; Pirola CJ
    Sleep; 2007 Aug; 30(8):1049-53. PubMed ID: 17702275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors.
    Sutcliffe JS; Delahanty RJ; Prasad HC; McCauley JL; Han Q; Jiang L; Li C; Folstein SE; Blakely RD
    Am J Hum Genet; 2005 Aug; 77(2):265-79. PubMed ID: 15995945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoxetine-induced alterations in human platelet serotonin transporter expression: serotonin transporter polymorphism effects.
    Little KY; Zhang L; Cook E
    J Psychiatry Neurosci; 2006 Sep; 31(5):333-9. PubMed ID: 16951736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin transporter gene polymorphisms and hyperserotonemia in autistic disorder.
    Betancur C; Corbex M; Spielewoy C; Philippe A; Laplanche JL; Launay JM; Gillberg C; Mouren-Siméoni MC; Hamon M; Giros B; Nosten-Bertrand M; Leboyer M
    Mol Psychiatry; 2002; 7(1):67-71. PubMed ID: 11803447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin transporter gene promoter variants do not explain the hyperserotoninemia in autistic children.
    Persico AM; Pascucci T; Puglisi-Allegra S; Militerni R; Bravaccio C; Schneider C; Melmed R; Trillo S; Montecchi F; Palermo M; Rabinowitz D; Reichelt KL; Conciatori M; Marino R; Keller F
    Mol Psychiatry; 2002; 7(7):795-800. PubMed ID: 12192626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression.
    Mathews TA; Fedele DE; Coppelli FM; Avila AM; Murphy DL; Andrews AM
    J Neurosci Methods; 2004 Dec; 140(1-2):169-81. PubMed ID: 15589347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoamine metabolites level in CSF is related to the 5-HTT gene polymorphism in treatment-resistant depression.
    Kishida I; Aklillu E; Kawanishi C; Bertilsson L; Agren H
    Neuropsychopharmacology; 2007 Oct; 32(10):2143-51. PubMed ID: 17299512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression.
    Maron E; Tammiste A; Kallassalu K; Eller T; Vasar V; Nutt DJ; Metspalu A
    Eur Neuropsychopharmacol; 2009 Jun; 19(6):451-6. PubMed ID: 19272758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.